You know those ads on late-night radio or in the back of some magazines for testosterone replacement therapy? Hate to be the bearer of bad news, but for older men that’s no real path to a male fountain of youth.
Like it or not, low testosterone is a normal part of aging and “fixing” it can be risky. Despite some news reports on the benefits of testosterone replacement therapy, several recent studies show that the harms may outweigh benefits. Continue reading
Journalists are in love with reporting new findings about a disease and a particular risk factor, but they are not so keen on following what happens later and reporting on whether the finding was replicated – and just over half the time is later disproved.
This comes from a recent study in PLOS ONE by authors who previously found that journalists tend to favor initial findings over subsequent findings on the same outcome. Continue reading
With thousands of medical studies published every day, it’s impossible to cover even 1 percent of them. When you can only choose a tiny fraction of studies to cover — particularly if you freelance or your editor gives you some autonomy and flexibility in this area — how do you decide whether or not to cover a study?
Reasons can vary: Some people focus on the better known “more prestigious” journals, although that approach has its drawbacks. Continue reading
Just one in every six new stories about medical research contained independent comments from someone besides the study authors — and a quarter of them did not have the relevant clinical or academic expertise to be commenting on the research. Further, just over half of those commenters had relevant conflicts of interest, but only half were reported in the news article. Those are the findings of a sobering, though unsurprising, new study that reveals just how much news consumers suffer from a dearth of high-quality reporting on medical research.
In plainer terms, health journalists need to be doing a better job when reporting on medical research. Continue reading
When it comes to social determinants and health, gender is one of the uncontrollable risk factors that can impact health. And while science still is exploring the extent of this impact, Consumer Reports recently examined six areas where differences have more clearly emerged.
These areas – colon cancer, heart attack, depression, smoking cessation, Alzheimer’s and Parkinson’s diseases – not only can have gender-specific symptoms but increasingly can benefit from more tailored care (including medication), according to Consumer Reports’ November On Health newsletter. Researchers also have begun to explore how gender affects pain and opioid use, it reported. Continue reading